#United States #San Juan #Prior Authorization #Healthcare Leaders #Abarca Health

Abarca Forward 2026: Pioneering a New Age in Healthcare

On February 25, 2026, Abarca Health hosted the significant fifth edition of Abarca Forward in San Juan, Puerto Rico. This event brought together esteemed healthcare executives from across the United States, focusing on the ambition to transform the protocols of prior authorization (PA) and utilization management (UM) in the healthcare landscape.

Abarca has long recognized that prior authorization processes have become increasingly cumbersome and frustrating for patients, providers, and insurers alike. The discussions at this year's event aimed not just to explore improvements, but to radically redesign these processes to create a more efficient, synergistic system. As Jason Borschow, Abarca Health’s CEO, expressed, "The solution is not merely automation; it’s a complete redesign of how we approach healthcare decisions."

Innovative Format to Encourage Collaboration

Departing from traditional conference styles with lectures and panels, Abarca Forward adopted a collaborative approach called the anti-conference. In this format, executives from health plans, providers, pharmacies, and technology companies engaged in structured co-creation sessions. The goal was to harmonize perspectives on PA so that it evolves into a supportive clinical decision-making tool rather than a bureaucratic hurdle.

This shift in perspective was evident as leaders explored how real-time regulations and standards impact their operations. Borschow stated, "Prior authorization shouldn’t feel like a battle; it should align data, clinical wisdom, and incentives for smoother transitions in patient care."

Key Speakers Share Vision and Strategies

One of the highlights of the event was an interview featuring Chris Klomp, Chief Counselor at the U.S. Department of Health and Human Services (HHS). Klomp affirmed that policy is gradually adapting to the rapid pace of innovation, which is vital for health plans and providers aiming for improved outcomes. The discussion ignited ideas about future standards for electronic prior authorization and the importance of aligning with technological advancements.

Speakers from various sectors, including Tanvi Patel from Amazon Pharmacy and executives from Microsoft and Blue Cross NC, shared their insights on integrating AI into workflows and the challenges of managing specialty drugs. The discussions highlighted the need for a unified approach among stakeholders, which many participants felt was lacking in the current system.

Collaborative Strategies to Enhance Patient Experience

The pinnacle of Abarca Forward 2026 was a hands-on workshop that united varied stakeholders—including health plans, technology leaders, employers, and patients—to develop foundational principles for a reimagined prior authorization process. The workshop aimed to cultivate a shared understanding of PA's role in enhancing the patient’s journey from care to coverage.

Outcomes from this workshop will be compiled into a strategic playbook designed to guide all participants towards actionable objectives that can be integrated into their practices. Such initiatives promise to expedite the approval process, enhance transparency, and ultimately create a better patient experience.

In summary, Abarca Forward 2026 was not just a conference; it was a collaborative movement aiming to tackle the long-standing issues that plague healthcare authorization processes. By empowering stakeholders to engage directly and constructively, Abarca is setting the stage for a more cohesive, effective model of care that centers on the patient’s experience and the provider’s needs.

For those looking to learn more about these initiatives and how they may impact the future of healthcare in the U.S., you may visit www.abarcaforward.com.

About Abarca Health

Abarca Health is committed to transforming healthcare into a seamless and personalized experience. By leveraging innovative technology, they manage an impressive $14 billion in annual drug spending, impacting the lives of approximately 7.5 million individuals nationally. The organization is focused on driving progress within the industry, all while ensuring that healthcare remains accessible and patient-centered.